CefodoxyMir-CV 325 is a combination antibiotic formulation containing Cefpodoxime Proxetil 200 mg + Potassium Clavulanate equivalent to Clavulanic Acid 125 mg, used for the treatment of susceptible bacterial infections.

Formulation: Cefpodoxime 200 mg + Potassium Clavulanate 125 mg
Packaging: 1 × 10 Tablets / 10 × 1 × 10 Tablets

Product Description:
CefodoxyMir-CV 325 combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor to provide enhanced antibacterial coverage against susceptible organisms. It may be prescribed for respiratory tract, urinary tract, skin and soft-tissue, and other bacterial infections, as determined by a qualified healthcare professional.